Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice

Fundamental and Applied Toxicology

Volumn 30, Issue 1, 1996, Pages 145-151

  Carlton, Betsy D ^a   Aubrun, Jean Claude ^b   Simon, Glenn S ^a  

^a Rhone Poulenc   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENICITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LIVER TUMOR; LIVER WEIGHT; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERINATAL PERIOD; RAT; SURVIVAL; WEIGHT GAIN;

ANIMALIA;

EID: 85033050877     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0051     Document Type: Article

References (26)

1. Bär, F. U., and Griepentrog, F. (1967). Die Situation in der gesundheitlichen Beurteilung der aromatisierungsmittell für lebensmittel. Med. Ernärhr. 8, 244.
2. Cohen, A. J. (1979). Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food Cosmet. Toxicol. 17, 277-289.
3. Dexeus, F. H., Logothetis, C. J., Sella, A., Fitz, K., Amato, R., Reuben, J. M., and Dozier, N. (1990). Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 8, 325-329.
4. Endell, W., and Seidel, G. (1978). Coumarin toxicity in different strains of mice. Agents Actions 8, 299-302.
5. Evans, J. G., Gaunt, I. F, and Lake, B. G. (1979). Two-year toxicity study on coumarin in the baboon. Food Cosmet. Toxicol. 17, 187-193.
6. Evans, J. G., Appleby, E. C., Lake, B. G., and Conning, D. M. (1989). Studies on the induction of cholangiofibrosis by coumarin the rat. Toxicology 55, 207-224.
7. Feuer, G., Golberg, L., and Gibson, K. I. (1966). Liver response tests. VII. Coumarin metabolism in relation to the inhibition of rat-liver glucose 6-phosphatase. Food Cosmet. Toxicol. 4, 157-167.
8. Gangolli, S. D., Shilling, W. H., Grasso, P., and Gaunt, L. F. (1974). Studies on the metabolism and hepatotoxicity of coumarin in the baboon. Biochem. Soc. Trans. 2, 310-312.
9. Hagan, E. C., Hansen, W. H., Fitzhugh, O. G., Jenner, P. M., Jones, W. I., Taylor, J. M., Long, E. L., Nelson, A. M., and Brouwer, J. B. (1967). Food flavorings and compounds of related structure. II. Subacute and chronic toxicity. Food Cosmet. Toxicol. 5(2), 141-157.
10. Hunter, B., Warren, S., Heywood, R. C., and Gibson, W. (1980). Huntingdon Research Centre, unpublished Rhône-Poulenc Rep. RNP 173/81137.
11. Jamal, S., Casley-Smith, J. R, and Casley-Smith, J. R. (1989). The effects of 5,6-benzo-[a]-pyrone (coumarin) and DEC on filaritic lymphoedema and elephantiasisin India. Ann. Trop. Med. Parasitol. 83(3), 287-290.
12. Lake, B. G. (1984). Investigations into the mechanism of coumarin-induced hepatoxicity in the rat. Arch. Toxicol. (Suppl. 7), 16-29.
13. Lake, B. G., Gray, T. J., Evans, J. G., Lewis, D. F. V., Beamand, J. A., and Hue, K. L. (1989). Studies on the mechanism of coumarin-indiced toxicity in rat hepatocytes: Comparison with dihydrocoumarin and other coumarin metabolites. Toxicol. Appl. Pharmacol. 97, 311-323.
14. 14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Food Chem. Toxicol. 30(2), 105-115.
15. Marshal, M. E., Mendelsohn, L., Butler, K., Riley, L., Cantrell, J., Wiseman, C., Taylor, R., and MacDonald, J. S. (1987a). Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: A pilot study. J. Clin. Oncol. 5(6), 862-866.
16. Marshall, M. E., Mendelsohn, L., Butler, K., Cantrell, J., Harvey, J., and MacDonald, J. S. (1987b). Treatment of non-small cell lung cancer with coumarin and cimetidine 1,2. Cancer Treat. Rep. 71(1), 91-92.
17. Marshall, L., Butler, K., Cantrell, J., Wiseman, C., and Mendelsohn, L. (1987c). Treatment of advanced malignant melanoma with coumarin and cimetidine: A pilot study. Cancer Chemother. Pharmacol. 24, 65-66.
18. Miles, J. S., McLaren, A. W., Forrester, L. M., Glancey, M. J., Lang, M. A., and Wolf, C. R. (1990). Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem. J. 267, 365-371.
19. Moran, E., O'Kennedy, R., and Thornes, R. D. (1987). Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J. Chromatogr. 416, 165-169.
20. National Toxicology Program (1993). Toxicology and carcinogenesis studies of coumarin (CAS No. 91-64-5) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Department of Heath and Human Services, Public Heath Service, National Institutes of Heath, Research Triangle Park, NC. Technical Rep. Series No. 422, NIH Publication No. 92-3153.
21. 14C] coumarin by rat hepatic microsomes. Xenobiotica 21, 499-514.
22. Shilling, W. H., Crampton, R. F., and Longland, R. C. (1969). Metabolism of coumarin in man. Nature 221, 664-665.
23. Thornes, D., Daly, L., Lynch, G., Browne, H., Tanner, A., Keane, F., O'Loughlin, S., Corrigan, T., Daly, P., Edwards, G., Breslin, B., Brown, H., Shine, M., Lennon, F., Hanley, J., McMurray, N., and Gaffrey, E. (1989). Prevention of early recurrence of high risk malignant melanoma by coumarin. Eur. J. Surg. Oncol. 15, 431-435.
24. Ueno, I., and Hirono, I. (1980). Non-carcinogenic response to coumarin in Syrian golden hamsters. Food Cosmet. Toxicol. 19, 353-355.
25. Williams, R. T., Millburn, P., and Smith, R. L. (1965). The influence of enterohepatic circulation on toxicity of drugs. Ann. N. Y. Acad. Sci. 123, 110.
26. Wood, A. W., and Conney, A. H. (1974). Genetic variation in coumarin hydroxylase activity in the mouse (mus musculus). Science 185 (4151), 612-614.